Fiberoptic Bronchoscopic Balloon Dilatation of Bronchial Stenosis in Children

Mehmet Köse1, Melih Hangül1, Gözde Nur Erkan2

  • 1Department of Pediatrics, Division of Pediatric Pulmonology.

Insights

Fiberoptic bronchoscopic balloon dilatation (BBD) is a safe and effective treatment for pediatric bronchial stenosis. This minimally invasive procedure offers a promising first-line option for children experiencing this rare condition.

Area of Science:

  • Pediatric Pulmonology
  • Interventional Pulmonology
  • Pediatric Bronchology

Background:

  • Bronchial stenosis is a rare condition in children.
  • Treatment options for pediatric bronchial stenosis are limited.
  • Fiberoptic bronchoscopic balloon dilatation (BBD) is an emerging therapeutic modality.

Purpose of the Study:

  • To evaluate the safety and efficacy of BBD as a primary treatment for bronchial stenosis in pediatric patients.
  • To identify the causes and outcomes of BBD in children.

Main Methods:

  • A retrospective study of 7 pediatric patients diagnosed with bronchial stenosis.
  • All patients underwent fiberoptic bronchoscopic balloon dilatation (BBD) as the initial treatment.
  • Data collected included patient demographics, underlying causes, procedure details, complications, and clinical outcomes.

Main Results:

  • Ten BBD procedures were performed on 7 children (median age 10 months).
  • Common causes included prolonged intubation/prematurity (4), extubation failure (2), and malignancy/recurrent pneumonia (1).
  • A single complication (laceration) occurred in 2 patients, with a median symptom-free duration of 11 months.

Conclusions:

  • Fiberoptic bronchoscopic balloon dilatation (BBD) is a safe and effective first-line treatment for pediatric bronchial stenosis.
  • BBD offers a minimally invasive approach with favorable outcomes in children.
  • Further research may support BBD as a standard of care for this condition.
Abstract

Related Concept Videos

The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
6.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
549
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
578
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
277
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
285
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
283